Agreed... and so the Primary end point appears to be THE be all and end all.
Do you agree that had MSB changed their primary end point to 3 point MACE pre trial, and run the same trial with the same results, and the hypothesis they now have, that the FDA would approve?
Apparently I keep hearing the MOA does not even need to be precisely understood, so a 50% reduction in heart attacks and stroke among the 500 person 5 year study... should have been enough?
MSB $1 Party, page-678
-
- There are more pages in this discussion • 471 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
92.8¢ |
Change
0.043(4.80%) |
Mkt cap ! $1.061B | |||
| Open | High | Low | Value | Volume |
| 88.5¢ | 95.0¢ | 88.0¢ | $2.754M | 3.003M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 31827 | 92.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 93.0¢ | 37761 | 7 |
View Market Depth
| Last trade - 11.57am 06/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |